Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2021

Open Access 01-12-2021 | Acute Lymphoblastic Leukemia | Case report

Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report

Authors: Ibrahim O. Ahmed, Lauretta O. Ochogwu, Temilola O. Owojuyigbe, Norah O. Akinola, Muheez A. Durosinmi

Published in: Journal of Medical Case Reports | Issue 1/2021

Login to get access

Abstract

Background

The occurrence of acute leukemia in patients with sickle cell anemia is uncommon. The Philadelphia chromosome is the hallmark of chronic myeloid leukemia. However, it may also be associated with acute lymphoblastic leukemia and acute myeloblastic leukemia. The common BCR-ABL1 transcripts seen in acute lymphoblastic leukemia are e1a2, e13a2, and e14a2, while other transcripts such as e1a3, e13a3, and e6a2 occur rarely. This report describes the presentation, management, and outcome of the occurrence of B-cell acute lymphoblastic leukemia with the rare e1a3 BCR-ABL1 transcript in a patient with sickle cell anemia.

Case presentation

A 19-year-old male Nigerian, a known sickle cell anemia patient was admitted on account of severe vaso-occlusive crisis. Examination revealed fever, palor, and jaundice. Full blood count showed anemia and leukocytosis. Peripheral blood and bone marrow smears revealed numerous large and small lymphoblasts in keeping with the L2 subtype of acute lymphoblastic leukemia based on the French–American–British classification. Further evaluation was in keeping with a diagnosis of BCR-ABL1-positive mature B-cell acute lymphoblastic leukemia associated with the rare e1a3 transcript. He was commenced simultaneously on induction chemotherapy and Imatinib while being prepared for allogeneic stem cell transplantation. However, he died  six  months after diagnosis from meningoencephalitis.

Conclusion

The occurrence of acute lymphoblastic leukemia with a rare BCR-ABL1 e1a3 transcript in association with sickle cell anemia is uncommon and associated with poor prognosis.
Literature
1.
go back to reference World Health Organization. Sickle-cell anaemia. Report by the Secretariat. Provisional agenda item 11.4 A59/9. 2006. World Health Organization. Sickle-cell anaemia. Report by the Secretariat. Provisional agenda item 11.4 A59/9. 2006.
2.
go back to reference Aworanti OW, Fasola FA, Kotila TR, Olaniyi JA, Brown BJ. Acute leukemia in sickle cell disease patients in a tertiary health facility in Nigeria: a case series. Afr Health Sci. 2020;20(3):1304–12.CrossRef Aworanti OW, Fasola FA, Kotila TR, Olaniyi JA, Brown BJ. Acute leukemia in sickle cell disease patients in a tertiary health facility in Nigeria: a case series. Afr Health Sci. 2020;20(3):1304–12.CrossRef
3.
go back to reference Bello-Manga H, Babadoko A, Hassan A, Mamman A, Awwalu S, Adebayo A, et al. Acute myeloid leukaemia in a patient with sickle cell disease: a case report and literature review. Arch Med Surg. 2016;1(1):12–6. Bello-Manga H, Babadoko A, Hassan A, Mamman A, Awwalu S, Adebayo A, et al. Acute myeloid leukaemia in a patient with sickle cell disease: a case report and literature review. Arch Med Surg. 2016;1(1):12–6.
4.
go back to reference Kang Z-J, Liu Y-F, Xu L-Z, Long Z-J, Huang D, Yang Y, et al. The Philadelphia chromosome in leukemogenesis. Chin J Cancer. 2016;35(1):48.CrossRef Kang Z-J, Liu Y-F, Xu L-Z, Long Z-J, Huang D, Yang Y, et al. The Philadelphia chromosome in leukemogenesis. Chin J Cancer. 2016;35(1):48.CrossRef
5.
go back to reference Melo J. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype [editorial; comment]. Blood. 1996;88(7):2375–84.CrossRef Melo J. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype [editorial; comment]. Blood. 1996;88(7):2375–84.CrossRef
6.
go back to reference Burmeister T, Schwartz S, Taubald A, Jost E, Lipp T, Schneller F, et al. Atypical BCR-ABL mRNA transcripts in adult acute lymphoblastic leukemia. Haematologica. 2007;92(12):1699–702.CrossRef Burmeister T, Schwartz S, Taubald A, Jost E, Lipp T, Schneller F, et al. Atypical BCR-ABL mRNA transcripts in adult acute lymphoblastic leukemia. Haematologica. 2007;92(12):1699–702.CrossRef
7.
go back to reference Baccarani M, Iacobucci I, Chiaretti S. Foà’ R, Balasubramanian P, Paietta E, et al. In Ph+BCR-ABL1P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent. Leukemia. 2020;34(3):929–31. Baccarani M, Iacobucci I, Chiaretti S. Foà’ R, Balasubramanian P, Paietta E, et al. In Ph+BCR-ABL1P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent. Leukemia. 2020;34(3):929–31.
8.
go back to reference Bassan R, Hoelzer D. Modern therapy of acute lymphoblastic leukemia. J Clin Oncol. 2011;29(5):532–43.CrossRef Bassan R, Hoelzer D. Modern therapy of acute lymphoblastic leukemia. J Clin Oncol. 2011;29(5):532–43.CrossRef
9.
go back to reference Durosinmi MA. Haemato-oncology chemotherapy for medical students and doctors. 3rd ed 2013. p. 15-17. Durosinmi MA. Haemato-oncology chemotherapy for medical students and doctors. 3rd ed 2013. p. 15-17.
10.
go back to reference Mukhopadhyay A, Gangopadhyay S, Dasgupta S, Paul S, Mukhopadhyay S, Ray UK. Surveillance and expected outcome of acute lymphoblastic leukemia in children and adolescents: an experience from Eastern India. Indian J Med Paediatr Oncol. 2013;34(4):280–2.CrossRef Mukhopadhyay A, Gangopadhyay S, Dasgupta S, Paul S, Mukhopadhyay S, Ray UK. Surveillance and expected outcome of acute lymphoblastic leukemia in children and adolescents: an experience from Eastern India. Indian J Med Paediatr Oncol. 2013;34(4):280–2.CrossRef
11.
go back to reference Pandey A, Ahlawat S, Singh A, Singh S, Murari K, Aryan R. Outcomes and impact of minimal residual disease (MRD) in pediatric, adolescent and young adults (AYA) with acute lymphoblastic leukemia treated with modified MCP 841 protocol. Cancer Res Stat Treatm. 2020;3(2):183–91.CrossRef Pandey A, Ahlawat S, Singh A, Singh S, Murari K, Aryan R. Outcomes and impact of minimal residual disease (MRD) in pediatric, adolescent and young adults (AYA) with acute lymphoblastic leukemia treated with modified MCP 841 protocol. Cancer Res Stat Treatm. 2020;3(2):183–91.CrossRef
12.
go back to reference Brunson A, Keegan THM, Bang H, Mahajan A, Paulukonis S, Wun T. Increased risk of leukemia among sickle cell disease patients in California. Blood. 2017;130(13):1597–9.CrossRef Brunson A, Keegan THM, Bang H, Mahajan A, Paulukonis S, Wun T. Increased risk of leukemia among sickle cell disease patients in California. Blood. 2017;130(13):1597–9.CrossRef
13.
go back to reference Dosunmu A, Akinbami A, Uche E, Adediran A, John-Olabode S. Electrocardiographic study in adult homozygous sickle cell disease patients in Lagos Nigeria. J Trop Med. 2016;2016:4214387–92.CrossRef Dosunmu A, Akinbami A, Uche E, Adediran A, John-Olabode S. Electrocardiographic study in adult homozygous sickle cell disease patients in Lagos Nigeria. J Trop Med. 2016;2016:4214387–92.CrossRef
14.
go back to reference Roman J, Jimenez A, Barrios M, Castillejo JA, Maldonado J, Torres A. E1A3 as a unique, naturally occurring BCR–ABL transcript in an indolent case of chronic myeloid leukaemia. Br J Haematol. 2001;114(3):635–7.CrossRef Roman J, Jimenez A, Barrios M, Castillejo JA, Maldonado J, Torres A. E1A3 as a unique, naturally occurring BCR–ABL transcript in an indolent case of chronic myeloid leukaemia. Br J Haematol. 2001;114(3):635–7.CrossRef
15.
go back to reference Al-Ali H-K, Leiblein S, Kovacs I, Hennig E, Niederwieser D, Deininger MWN. CML with an e1a3 BCR-ABL fusion: rare, benign, and a potential diagnostic pitfall. Blood. 2002;100(3):1092–3.CrossRef Al-Ali H-K, Leiblein S, Kovacs I, Hennig E, Niederwieser D, Deininger MWN. CML with an e1a3 BCR-ABL fusion: rare, benign, and a potential diagnostic pitfall. Blood. 2002;100(3):1092–3.CrossRef
16.
go back to reference Tabassum N, Ghani R, Saboor M, Moinuddin M. Chronic myeloid leukemia with rare e1a3 BCR-ABL transcript. Pakistan J Med Dent. 2015;4:1. Tabassum N, Ghani R, Saboor M, Moinuddin M. Chronic myeloid leukemia with rare e1a3 BCR-ABL transcript. Pakistan J Med Dent. 2015;4:1.
17.
go back to reference Martinez-Serra J, del Campo R, Gutierrez A, Antich JL, Ginard M, Durán MA, et al. Chronic myeloid leukemia with an e1a3 BCR-ABL fusion protein: transformation to lymphoid blast crisis. Biomarker Res. 2014;2(1):14.CrossRef Martinez-Serra J, del Campo R, Gutierrez A, Antich JL, Ginard M, Durán MA, et al. Chronic myeloid leukemia with an e1a3 BCR-ABL fusion protein: transformation to lymphoid blast crisis. Biomarker Res. 2014;2(1):14.CrossRef
18.
go back to reference Nieborowska-Skorska M, Wasik MA, Slupianek A, Salomoni P, Kitamura T, Calabretta B, et al. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis. J Exp Med. 1999;189(8):1229–42.CrossRef Nieborowska-Skorska M, Wasik MA, Slupianek A, Salomoni P, Kitamura T, Calabretta B, et al. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis. J Exp Med. 1999;189(8):1229–42.CrossRef
19.
go back to reference Tiribelli M, Tonso A, Ferrero D, Parziale A, Cambrin GR, Scaravaglio P, et al. Lack of SH3 domain does not imply a more severe clinical course in Ph+ chronic myeloid leukemia patients. Blood. 2000;95(12):4019–20.CrossRef Tiribelli M, Tonso A, Ferrero D, Parziale A, Cambrin GR, Scaravaglio P, et al. Lack of SH3 domain does not imply a more severe clinical course in Ph+ chronic myeloid leukemia patients. Blood. 2000;95(12):4019–20.CrossRef
20.
go back to reference Huang FL, Liao EC, Li CL, Yen CY, Yu SJ. Pathogenesis of pediatric B-cell acute lymphoblastic leukemia: molecular pathways and disease treatments. Oncol Lett. 2020;20(1):448–54.CrossRef Huang FL, Liao EC, Li CL, Yen CY, Yu SJ. Pathogenesis of pediatric B-cell acute lymphoblastic leukemia: molecular pathways and disease treatments. Oncol Lett. 2020;20(1):448–54.CrossRef
21.
go back to reference Yilmaz M, Kantarjian H, Ravandi-Kashani F, Short NJ, Jabbour E. Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: current treatments and future perspectives. Clin Adv Hematol Oncol. 2018;16(3):216–23.PubMed Yilmaz M, Kantarjian H, Ravandi-Kashani F, Short NJ, Jabbour E. Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: current treatments and future perspectives. Clin Adv Hematol Oncol. 2018;16(3):216–23.PubMed
22.
go back to reference Tanimura K, Yamasaki K, Okuhiro Y, Hira K, Nitani C, Okada K, et al. Monitoring ponatinib in a child with Philadelphia chromosome-positive acute lymphoblastic leukemia. Case Rep Oncol. 2021;14(1):24–8.CrossRef Tanimura K, Yamasaki K, Okuhiro Y, Hira K, Nitani C, Okada K, et al. Monitoring ponatinib in a child with Philadelphia chromosome-positive acute lymphoblastic leukemia. Case Rep Oncol. 2021;14(1):24–8.CrossRef
23.
go back to reference Jabbour E, Thomas D, Cortes J, Kantarjian HM, O’Brien S. Central nervous system prophylaxis in adults with acute lymphoblastic leukemia. Cancer. 2010;116(10):2290–300.PubMed Jabbour E, Thomas D, Cortes J, Kantarjian HM, O’Brien S. Central nervous system prophylaxis in adults with acute lymphoblastic leukemia. Cancer. 2010;116(10):2290–300.PubMed
24.
go back to reference Lin W-Y, Liu H-C, Yeh T-C, Wang L-Y, Liang D-C. Triple intrathecal therapy without cranial irradiation for central nervous system preventive therapy in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;50(3):523–7.CrossRef Lin W-Y, Liu H-C, Yeh T-C, Wang L-Y, Liang D-C. Triple intrathecal therapy without cranial irradiation for central nervous system preventive therapy in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;50(3):523–7.CrossRef
25.
go back to reference Muriel FS, Svarch E, Pavlovsky S, Eppinger-Helft M, Braier J, Vergara B, et al. Comparison of central nervous system prophylaxis with cranial radiation and intrathecal methotrexate versus intrathecal methotrexate alone in acute lymphoblastic leukemia. Blood. 1983;62(2):241–50.CrossRef Muriel FS, Svarch E, Pavlovsky S, Eppinger-Helft M, Braier J, Vergara B, et al. Comparison of central nervous system prophylaxis with cranial radiation and intrathecal methotrexate versus intrathecal methotrexate alone in acute lymphoblastic leukemia. Blood. 1983;62(2):241–50.CrossRef
26.
go back to reference Pui C-H, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360(26):2730–41.CrossRef Pui C-H, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360(26):2730–41.CrossRef
27.
go back to reference Winter SS, Devidas M, Chen S, Asselin B, Carroll WL, Wood BL, et al. Capizzi-style methotrexate with pegasparagase (C-MTX) Is superior to high-dose methotrexate (HDMTX) in T-lineage acute lymphoblastic leukemia (T-ALL): results from Children’s Oncology Group (COG) AALL0434. Blood. 2015;126(23):794–794.CrossRef Winter SS, Devidas M, Chen S, Asselin B, Carroll WL, Wood BL, et al. Capizzi-style methotrexate with pegasparagase (C-MTX) Is superior to high-dose methotrexate (HDMTX) in T-lineage acute lymphoblastic leukemia (T-ALL): results from Children’s Oncology Group (COG) AALL0434. Blood. 2015;126(23):794–794.CrossRef
28.
go back to reference Langabeer SE, Haslam K, Kelly J, Leahy M, Vandenberghe E. Acute lymphoblastic leukaemia with an e1a3 <i>BCR-ABL1</i> fusion. Acta Haematol. 2011;126(4):214–5.CrossRef Langabeer SE, Haslam K, Kelly J, Leahy M, Vandenberghe E. Acute lymphoblastic leukaemia with an e1a3 <i>BCR-ABL1</i> fusion. Acta Haematol. 2011;126(4):214–5.CrossRef
29.
go back to reference Shin SY, Cho JH, Kim HJ, Jang JH, Lee ST, Kim SH. Two cases of acute lymphoblastic leukemia with an e1a3 BCR-ABL1 fusion transcript. Ann Lab Med. 2015;35(1):159–61.CrossRef Shin SY, Cho JH, Kim HJ, Jang JH, Lee ST, Kim SH. Two cases of acute lymphoblastic leukemia with an e1a3 BCR-ABL1 fusion transcript. Ann Lab Med. 2015;35(1):159–61.CrossRef
30.
go back to reference Fujisawa S, Nakamura S, Naito K, Kobayashi M, Ohnishi K. A variant transcript, e1a3, of the minor BCR–ABL fusion gene in acute lymphoblastic leukemia: case report and review of the literature. Int J Hematol. 2008;87(2):184–8.CrossRef Fujisawa S, Nakamura S, Naito K, Kobayashi M, Ohnishi K. A variant transcript, e1a3, of the minor BCR–ABL fusion gene in acute lymphoblastic leukemia: case report and review of the literature. Int J Hematol. 2008;87(2):184–8.CrossRef
31.
go back to reference López-Andrade B, Sartori F, Gutiérrez A, García L, Cunill V, Durán MA, et al. Acute lymphoblastic leukemia with e1a3 BCR/ABL fusion protein. A report of two cases. Exp Hematol Oncol. 2015;5:21.CrossRef López-Andrade B, Sartori F, Gutiérrez A, García L, Cunill V, Durán MA, et al. Acute lymphoblastic leukemia with e1a3 BCR/ABL fusion protein. A report of two cases. Exp Hematol Oncol. 2015;5:21.CrossRef
32.
go back to reference Malhotra P, Chauhan S, Bhatt P, Varma N, Chakrabarti A, Kumari S, et al. Cryptococcal meningitis in acute lymphoblastic leukemia. J Assoc Phys India. 2004;52:831–2. Malhotra P, Chauhan S, Bhatt P, Varma N, Chakrabarti A, Kumari S, et al. Cryptococcal meningitis in acute lymphoblastic leukemia. J Assoc Phys India. 2004;52:831–2.
33.
go back to reference Tagbo BN, Bancroft RE, Fajolu I, Abdulkadir MB, Bashir MF, Okunola OP, et al. Pediatric bacterial meningitis surveillance in Nigeria from 2010 to 2016, prior to and during the phased introduction of the 10-valent pneumococcal conjugate vaccine. Clin Infect Dis. 2019;69(Supplement_2):S81–8.CrossRef Tagbo BN, Bancroft RE, Fajolu I, Abdulkadir MB, Bashir MF, Okunola OP, et al. Pediatric bacterial meningitis surveillance in Nigeria from 2010 to 2016, prior to and during the phased introduction of the 10-valent pneumococcal conjugate vaccine. Clin Infect Dis. 2019;69(Supplement_2):S81–8.CrossRef
34.
go back to reference Castro I, Ruiz J, Tasias M, Montero M, Salavert M. Central nervous system infections in immunocompromised patients. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia. 2018;31(Suppl 1):56–61. Castro I, Ruiz J, Tasias M, Montero M, Salavert M. Central nervous system infections in immunocompromised patients. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia. 2018;31(Suppl 1):56–61.
35.
go back to reference Beaumont A-L, Suner L. Drug-induced aseptic meningitis in a Ph+ ALL patient with meningeal involvement. Blood. 2020;136(4):520–520.CrossRef Beaumont A-L, Suner L. Drug-induced aseptic meningitis in a Ph+ ALL patient with meningeal involvement. Blood. 2020;136(4):520–520.CrossRef
36.
go back to reference Kantarjian HM, Talpaz M, Giles F, O’Brien S, Cortes J. New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistance. Ann Intern Med. 2006;145(12):913–23.CrossRef Kantarjian HM, Talpaz M, Giles F, O’Brien S, Cortes J. New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistance. Ann Intern Med. 2006;145(12):913–23.CrossRef
Metadata
Title
Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report
Authors
Ibrahim O. Ahmed
Lauretta O. Ochogwu
Temilola O. Owojuyigbe
Norah O. Akinola
Muheez A. Durosinmi
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2021
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-021-03060-5

Other articles of this Issue 1/2021

Journal of Medical Case Reports 1/2021 Go to the issue